BPC-157 has no comparable body of completed, published human efficacy trials
Neither CJC-1295 nor Ipamorelin see our primer on what ipamorelin is has an approved human therapeutic indication, and the combined CJC-1295/Ipamorelin blend has not been approved as a finished drug product
One of its most significant advantages is its ability to reduce inflammation, a key factor in slowing down the healing process
Here is a summary of the potential benefits of BPC-157
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Larger doses of vitamin B12 can cause other more serious side effects including: Headache Nausea and vomiting Diarrhea Fatigue or weakness Tingling sensation in hands and feet Our doses are preservative free and extremely small, and therefore rarely cause a negative reaction